Eli Lilly's orforglipron outshines Novo Nordisk's oral semaglutide with efficacy & scalability, promising growth in obesity & diabetes markets.

We came across a bullish thesis on Sable Offshore Corp. on Stock Analysis Compilation’s Substack. In this article, we will ...

We came across a bullish thesis on Corporación América Airports S.A. on Stock Analysis Compilation’s Substack. In this ...

Okta stock price has crashed into a bear market after falling by 27% from its highest level this year. What next for the ...

Introducing Trading in the Zone Elementary – GTF’s flagship free stock market certification course, available on YouTube, the GTF App, and GTF’s official website. With over 3 million views, 1 lakh+ ...

The most recent U.S. Census Bureau data also shows CPS owes more than $28,000 per pupil, up from roughly $17,000 a decade ...

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered ...

As traditional advertising loses its grip, brands are embedding themselves more and more directly into the shows and movies ...

A ruling by the country’s highest court could definitively establish whether members of the public can legally access “corner ...

Growth investing, betting on rapidly expanding companies, has proved successful since 2008. But now the other main investment ...

The long decline of Kodak – a once-dominant company – shows why no business is safe from disruption, says Matthew Lynn ...

Understanding how financial statements influence valuation measures helps you spot both positive and negative changes.